Hosmani Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-11-2024
- Paid Up Capital ₹ 2.50 M
as on 16-11-2024
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
as on 16-11-2024
- Satisfied Charges ₹ 1.43 Cr
as on 16-11-2024
- Revenue -27.86%
(FY 2023)
- Profit -8.32%
(FY 2023)
- Ebitda -2.16%
(FY 2023)
- Net Worth 37.10%
(FY 2023)
- Total Assets 4.82%
(FY 2023)
About Hosmani Nutraceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹2.00 Cr. The company has closed loans amounting to ₹1.43 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gagandeep Hosamani and Ashok Fakeerappa serve as directors at the Company.
- CIN/LLPIN
U74900KA2015PTC080123
- Company No.
080123
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 May 2015
- Date of AGM
31 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Dharwad, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Hosmani Nutraceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gagandeep Hosamani  | Director | 06-May-2015 | Current |
| Ashok Fakeerappa | Director | 06-May-2015 | Current |
Financial Performance of Hosmani Nutraceuticals.
Hosmani Nutraceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 27.86% decrease. The company also saw a slight decrease in profitability, with a 8.32% decrease in profit. The company's net worth Soared by an impressive increase of 37.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hosmani Nutraceuticals?
In 2023, Hosmani Nutraceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Jun 2019 | ₹2.00 Cr | Open |
Others Creation Date: 22 Sep 2015 | ₹1.43 Cr | Satisfied |
How Many Employees Work at Hosmani Nutraceuticals?
Unlock and access historical data on people associated with Hosmani Nutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hosmani Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hosmani Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
